Cantor Fitzgerald Has Weak Forecast for ACRS FY2025 Earnings
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) – Equities researchers at Cantor Fitzgerald lowered their FY2025 earnings per share (EPS) estimates for Aclaris Therapeutics in a research report issued on Tuesday, March 18th. Cantor Fitzgerald analyst P. Agrawal now anticipates that the biotechnology company will post earnings per share of ($0.62) for the year, down […]
More Stories
Envestnet Portfolio Solutions Inc. Sells 5,525 Shares of Brown & Brown, Inc. (NYSE:BRO)
Envestnet Portfolio Solutions Inc. decreased its position in Brown & Brown, Inc. (NYSE:BRO – Free Report) by 33.2% in the...
Natixis Advisors LLC Buys 10,024 Shares of Warner Bros. Discovery, Inc. (NASDAQ:WBD)
Natixis Advisors LLC grew its stake in shares of Warner Bros. Discovery, Inc. (NASDAQ:WBD – Free Report) by 3.6% during...
Envestnet Portfolio Solutions Inc. Acquires 482 Shares of Waters Co. (NYSE:WAT)
Envestnet Portfolio Solutions Inc. boosted its holdings in Waters Co. (NYSE:WAT – Free Report) by 15.5% during the fourth quarter,...
BKM Wealth Management LLC Acquires 495 Shares of NVIDIA Co. (NASDAQ:NVDA)
BKM Wealth Management LLC grew its holdings in shares of NVIDIA Co. (NASDAQ:NVDA – Free Report) by 8.9% in the...
Evergreen Wealth Management LLC Takes Position in NVIDIA Co. (NASDAQ:NVDA)
Evergreen Wealth Management LLC purchased a new stake in NVIDIA Co. (NASDAQ:NVDA – Free Report) in the fourth quarter, according...
NVIDIA Co. (NASDAQ:NVDA) Holdings Lifted by Northstar Asset Management Inc.
Northstar Asset Management Inc. lifted its stake in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 8.7% in the fourth quarter,...